Thank you, and I marked you back! I'm glad we both can see the great potential here. If the company can pull off literally any of the things it says it plans to, it'll be a .01+ company. If they can pull it all off, who knows where this could go.
I like to think of UNGS as the stock to invest in for those who missed out on ERB* last year. We have similar business models and share structures, and for the longest time they didn't have a product either. Plus, Bud Bank looks a lot sexier than Zazzz!
We just have to produce BudBanks, show them off at cannabis shows, and have Anderson start putting out regular fins (even if they're bad at first) to restore faith in UNGS. I would also love to see the A/S come down to 5-billion at most. If you look around the MJ companies on the OTC, that is about the most shares a company can have authorized and still move based on my research (Ex. AVOP-9 billion A/S or so and can't get above trip-3 even on good news).
